Physician profile
Shubash Adhikari
NPI 1861809741
$58,634.41
in general payments reported to CMS, 2019-2025
18 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $519 · 2022: $3,577 · 2023: $8,852 · 2024: $25K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $27K · Grant: $14K · Food and Beverage: $12K · Education: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $27,473.99 |
| Grant | $14,000.00 |
| Food and Beverage | $11,592.90 |
| Education | $1,471.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19,607.59 | 2021-2025 | Ensite, Tacticath, Assurity |
| Medtronic, INC. | $18,960.38 | 2022-2025 | Micra, Selectsecure, Na |
| Boston Scientific Corporation | $8,908.30 | 2022-2024 | Versacross Access Solution, Watchman Access System |
| Biosense Webster, INC. | $4,598.77 | 2025 | Carto 3 |
| Medical Device Business Services, INC. | $3,388.97 | 2023-2024 | Carto 3 |
| Biotronik INC. | $907.49 | 2023-2025 | Orsiro Mission |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $733.04 | 2021-2024 | Lifevest |
| Heartflow, INC. | $383.08 | 2022-2023 | Ffrct |
| Astrazeneca Pharmaceuticals Lp | $349.60 | 2022-2024 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $283.16 | 2022-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $145.87 | 2022-2023 | Camzyos |
| Impulse Dynamics (USA) INC. | $103.18 | 2023 | Optimizer |
| Amgen INC. | $91.89 | 2021-2023 | Repatha |
| Abiomed | $51.83 | 2024 | Impella |
| Kestra Medical Technology Services, INC. | $43.64 | 2024 | Assure Wcd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $33.41 | 2021 | |
| Zoll Circulation INC | $22.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shubash Adhikari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.